SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -54.5% | 1,238 | -35.9% | 0.00% | – |
| Q1 2022 | $11,000 | -26.7% | 1,931 | -3.8% | 0.00% | – |
| Q4 2021 | $15,000 | -6.2% | 2,008 | +13.5% | 0.00% | – |
| Q3 2021 | $16,000 | -23.8% | 1,769 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -65.6% | 1,769 | -63.9% | 0.00% | -100.0% |
| Q1 2021 | $61,000 | +5.2% | 4,900 | +31.5% | 0.00% | 0.0% |
| Q4 2020 | $58,000 | +23.4% | 3,727 | -25.1% | 0.00% | 0.0% |
| Q3 2020 | $47,000 | +2.2% | 4,979 | +2.6% | 0.00% | 0.0% |
| Q2 2020 | $46,000 | – | 4,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |